Cargando…
Deprescription in Advanced Cancer Patients
The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectan...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164016/ https://www.ncbi.nlm.nih.gov/pubmed/30134513 http://dx.doi.org/10.3390/pharmacy6030088 |
_version_ | 1783359499757682688 |
---|---|
author | Gonçalves, Ferraz |
author_facet | Gonçalves, Ferraz |
author_sort | Gonçalves, Ferraz |
collection | PubMed |
description | The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectancy who, therefore, will not benefit from them. The reflection on this has led to the introduction of the concept of deprescription. There are many reasons for the inappropriate drug prescription and barriers to reduce medications. Tools were developed to help prescribers to limit the number of prescribed drugs that patients are taking. Several studies have shown that deprescription of some drugs is possible and safe and can even have a positive influence on wellbeing, cognitive function, falls, and admission to a hospital. Deprescription should be individualized and carried out, as far as possible, in agreement with patients and their families. A six-step method for deprescription is proposed. |
format | Online Article Text |
id | pubmed-6164016 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61640162018-10-10 Deprescription in Advanced Cancer Patients Gonçalves, Ferraz Pharmacy (Basel) Review The use of multiple drugs is often referred to as polypharmacy, although this term has not been precisely defined. Frequently, drugs are used unwisely in multiple combinations increasing the risk of adverse reactions, or for the long-term prevention of diseases in patients with a short life expectancy who, therefore, will not benefit from them. The reflection on this has led to the introduction of the concept of deprescription. There are many reasons for the inappropriate drug prescription and barriers to reduce medications. Tools were developed to help prescribers to limit the number of prescribed drugs that patients are taking. Several studies have shown that deprescription of some drugs is possible and safe and can even have a positive influence on wellbeing, cognitive function, falls, and admission to a hospital. Deprescription should be individualized and carried out, as far as possible, in agreement with patients and their families. A six-step method for deprescription is proposed. MDPI 2018-08-21 /pmc/articles/PMC6164016/ /pubmed/30134513 http://dx.doi.org/10.3390/pharmacy6030088 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Gonçalves, Ferraz Deprescription in Advanced Cancer Patients |
title | Deprescription in Advanced Cancer Patients |
title_full | Deprescription in Advanced Cancer Patients |
title_fullStr | Deprescription in Advanced Cancer Patients |
title_full_unstemmed | Deprescription in Advanced Cancer Patients |
title_short | Deprescription in Advanced Cancer Patients |
title_sort | deprescription in advanced cancer patients |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164016/ https://www.ncbi.nlm.nih.gov/pubmed/30134513 http://dx.doi.org/10.3390/pharmacy6030088 |
work_keys_str_mv | AT goncalvesferraz deprescriptioninadvancedcancerpatients |